Glyphic Biotechnologies
Glyphic Biotechnologies is a startup headquartered in New York, United States, founded in 2021. It has raised at least $33.2m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Glyphic Biotechnologies has raised at least $33.2m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Glyphic Biotechnologies sits inside the New York and New Jersey R&D ecosystem in the Global R&D Labs Directory.
Other startups in New York
Related
- Innovation profile of New York
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Glyphic Biotechnologies do?
Glyphic Biotechnologies is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Glyphic Biotechnologies raised?
At least $33.2m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Glyphic Biotechnologies based?
Glyphic Biotechnologies is headquartered in New York, United States.
When was Glyphic Biotechnologies founded?
Glyphic Biotechnologies was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.